LINCOLN logo

Lincoln Pharma LTD

LINCOLN·NSE·
612.00 +2.35 (+0.39%)
Market Cap1227.92 Cr
PE Ratio13.95
Volume9,357
Day High - Low620.00 - 605.40
52W High-Low770.00 - 440.00
DocStoX Score
6.1/10
Fair
Fair Value
Sign in to see
ROE
12.30%
Average
P/E
13.95x
Cheap
Debt / Equity
0.01
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

Day605.40
620.00
52W440.00
770.00
DocStoX take

Supported by risk (8.5) and valuation (6.7), but weakest on growth (4.3).

DocStoX score

Low confidence
6.1
/10
Fair
Quality
Solid
ROE 12.3%
Valuation
Fair
P/E 13.9×
Growth
Slow
Revenue +9.6% 5Y CAGR
Risk
Low risk
D/E 0.01
Momentum
Firm
52% of 52-week range

At a glance

Market Cap
₹1,228 Cr
52W High / Low
₹770 / ₹440
Dividend Yield
0.29%
Promoter Holding
49.78%
EPS (TTM)
₹43.88
Book Value
₹378.00

Key highlights

  • Low leverage — D/E 0.01
  • Profitable in all of the last 5 years
  • Undemanding at 14× earnings
3 Positives0 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

LINCOLN PHARMA LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

LINCOLN PHARMA LTD (LINCOLN) Share Price at ₹614.3 (+0.76%) | DocStoX